Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03135782 · ClinicalTrials.gov registry record · NA
Provider Training in Increasing Patient Tobacco Cessation Counseling and Referrals for Patients With Cancer Undergoing Radiation Therapy
A NA study of Breast Carcinoma and Tobacco Use, sponsored by OHSU Knight Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
- 1
- Study location
NCT03135782: Completed NA study of Breast Carcinoma and Tobacco Use, sponsored by OHSU Knight Cancer Institute.
NCT03135782 is a NA study of Breast Carcinoma and Tobacco Use that has completed, run by OHSU Knight Cancer Institute. The registered enrollment target is 2 participants, below the 770-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03135782, a NA study of Breast Carcinoma and Tobacco Use, has completed, sponsored by OHSU Knight Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot clinical trial studies how well provider training works in increasing patient tobacco cessation counseling and referrals for patients with cancer undergoing radiation therapy. Health care provider training in motivational interviewing techniques and utilizing tobacco cessation resources may help doctors understand how health care providers can effectively increase their confidence in talking to patients about tobacco cessation counseling.
Primary Outcome
Will be compared between the cohort of pre and post intervention. Will be summarized using descriptive statistics and compared using chi-square test by tumor type.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- OTHER Medical Chart Review
- OTHER Tobacco Cessation Counseling
- OTHER Communication Skills Training
Study Locations (1)
Oregon
- OHSU Knight Cancer Institute - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2020-09-23 |
| Phase | NA |
What the finished NCT03135782 record still lists
NCT03135782 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 770-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (100% lower).
The record links to 6 conditions, with Breast Carcinoma appearing as the primary indexed condition, and to 4 interventions - of which Questionnaire Administration is the first listed.
NCT03135782 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT03135782 about?
NCT03135782 is a clinical study titled "Provider Training in Increasing Patient Tobacco Cessation Counseling and Referrals for Patients With Cancer Undergoing Radiation Therapy". This pilot clinical trial studies how well provider training works in increasing patient tobacco cessation counseling and referrals for patients with cancer undergoing radiation therapy. Health care provider training in motivational interviewing techniques and utilizing tobacco cessation resources m...
What is the current status of trial NCT03135782?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2017-08-01. Estimated completion is 2020-09-23.
What conditions does trial NCT03135782 study?
This clinical trial studies the following conditions: Breast Carcinoma, Tobacco Use, Prostate Carcinoma, Lung Carcinoma, Head and Neck Carcinoma.
What interventions are being tested in trial NCT03135782?
The interventions under investigation include: Questionnaire Administration (OTHER), Medical Chart Review (OTHER), Tobacco Cessation Counseling (OTHER), Communication Skills Training (OTHER).
Who is sponsoring clinical trial NCT03135782?
This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03135782 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03135782's enrollment target sits among peer trials
2 107th of 106 the lowest of 106 other Breast Carcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Post-treatment Supportive Service Program for the Transition Into Survivorship for Black Women Breast Cancer Survivors in Western New York
RECRUITING · NA
-
Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Breast Cancer
RECRUITING · NA
-
An Imaging Technology, Contrast-Enhanced Mammography, in Predicting Breast Cancer
RECRUITING · NA
-
A 3D-Printed External Breast Prosthesis for the Improvement of Patient-reported Outcomes Among Breast Cancer Patients That Underwent a Mastectomy Without Reconstruction
RECRUITING · NA
-
Cancer Genetic Testing in Ethnic Populations
RECRUITING · NA
-
Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI